Industry investment in dementia research
Investment from industry, such as pharmaceutical and biotech companies, is critical for advancing our understanding of dementia and developing new treatments and therapies for those living with dementia. Investment from industry can help accelerate the pace of research and improve the chances of finding life-changing treatments for dementia.
ARUK report: The Economic Value of Dementia Research.
Industry and non-industry sponsored dementia trials
Industry
sponsored
clinical trials
ARUK report: The Economic Value of Dementia Research.
Almost all phase 3 clinical trials in the UK are funded by industry
industry
funding
clinical
trials
phase 3
ARUK report: The Economic Value of Dementia Research.